$50 is the new $5….
The Market: As expected, volatility continues and $50 point swings are becoming as common as $5 point swings use to be. We expect volatility to remain high but would not be surprised to see the magnitude of the swing start to temper. Today was important because after two straight days of gap ups that sold off into the close, today managed to hold and extend on the gap after an intraday pullback. As we noted in Monday’s write-up, the market is very short-term oversold and we would expect a bounce so today’s action is not surprising but we will be…
Yellen sends stocks screaming, dollar dropping
Index & Sector performance 3/18/15 The Market: After the FOMC rate decision at 2pm ET, the S&P 500 cash index rallied nearly 40 points from the lows to the highs and did so, astonishingly, in less than 2 hours but the more impressive move may have been in the U.S. Dollar which moved strongly lower and continued its decline in the after hours tagging 1.10 in the EUR/USD exchange after trading below 1.05 Monday. The U.S. Dollar has shown remarkable strength on late so it is not surprising to see a give back and considering how far how fast we…
EPS helped shrug off bad overseas data
Index & Sector performance 11/20/14 The Market: It doesn’t look like the S&P 500 (SPY) had a strong session but considering the futures were down roughly 10 points pre-market reportedly due to weak data out of Europe and China, to finish up a few points is a strong showing. Yesterday’s laggard was today’s leader as the Russell 2000 (IWM ) finished up over 1% clawing back most of yesterday’s losses and the Dow (DIA) was helped by Intel (INTC) which gained 4.66% after announcing a dividend hike and solid 2015 expected revenue growth. In individual sectors, Retail (XRT) led today…
Merger Monday doesn’t help market
Index & Sector performance 11/17/14 The Market: Despite a very active M&A session, it was yet another very tight trading range in the S&P 500 while the NASDAQ (QQQ) lagged and the Russell 2000 (IWM) led to the downside. In deals we saw Allergan (AGN) agree to be acquired by Actavis (ACT) for a combination of cash and ACT stock which totaled $219 per share. Valeant Pharmaceuticals (VRX) who had also been trying to buy AGN stepped aside not feeling comfortable they could justify the valuation to shareholders. Two more big names in M&A news as Halliburton (HAL) announced it…